Download a patient information leaflet on Dupuytren's Disease from the British Society for Surgery.
Update: The Scottish Medicines Consortium (SMC) has agreed to restricted use of Xiapex within the NHS in Scotland. It is now up to every trust to organise their own local protocols.
Mr Broadbent undertakes the Xiapex Clinic for the West of Scotland (NHS). If you are keen to consider Xiapex as a treatment for your contracture, please ask your GP to refer you to Mr Mark Broadbent at Inverclyde Royal Hospital.
The SMC’s statement was:
SMC restriction: restricted to use as an alternative to limited fasciectomy in adult patients with Dupuytren’s contracture of moderate severity (as defined by the British Society for Surgery of the Hand (BSSH)), with a palpable cord and up to two affected joints per hand, who are suitable for limited fasciectomy, but for whom percutaneous needle fasciotomy is not considered a suitable treatment option.
The BSSH definition of moderate severity is:
■ Notable functional problems
■ Moderate metacarpo-phalangeal joint contracture (30° - 60° ).
■ Moderate proximal inter-phalangeal joint contracture (<30°).
■ First web contracture
Patient Leaflet Download